In addition, previous studies report that SMAD6 is highly expressed in pancreatic cancers and enhances anchorage-independent growth in pancreatic cancer cells by blocking TGF-β-mediated growth inhibition45. Here, SMAD6 is linked to familial pancreatic carcinoma.